5 trends in the BMP market — spinal fusion has largest market share

Written by Laura Dyrda | December 13, 2016 | Print  |

The bone morphogenetic protein market is expected to grow over the next eight years, according to a Grand View Research report.

Here are five key trends:


1. The BMP market is expected to reach $644.6 million in 2024. The increase of spinal fusions, trauma and small bone surgeries will drive the increase over time.


2. In 2015, rhBMP-2 had more than half the market share for BMPs due to a higher acceptance rate among surgeons, wide application range and ease of availability in developing countries.


3. The use of rhBMP-7 is expected to drop in market share over the next few years, especially after Olympus discontinued OP-1 in 2014.


4. Spinal fusion reported the largest market share of BMP use in 2015.


5. North America accounted for 65 percent of the BMP market in 2015 with a high number of orthopedic surgeries available and favorable reimbursement policies in the country.


More articles on orthopedic devices:
SeaSpine names William Rhoda to new executive position
Global biological implant market to total $9.8B by 2024
ISASS issues policy statement recommending coverage of decompression with interlaminar stabilization

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months